ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Hiberix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung - Set(s)
00603001 GlaxoSmithKline AG
Hiberix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung15.09.1997
  15.09.1997
Haemophilus Influenzae B, Purified Antigen Conjugated (J07AG01) 
WHO-DDD 
08.08.Set(s)
08.08. 
B  
Yes 
IP 
16.16Yes
    
10 %34.00
  
7680006030015Impfstoffe
  
Composition
Praeparatio cryodesiccata: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, pro praeparatione. Solvens: natrii chloridum corresp. natrium 1.77 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Packungsbestandteile
Active AgentDose
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
BAG: Active AgentDose
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
Praeparatio cryodesiccata:
 
Lyophilisate and solvent 
  
  
BAG: Active AgentDose
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
 
Inactive agentsDose
Conjugata cum Toxoido Tetani10 µg
Lactosum 
Polysaccharida Haemophili Influenzae Typus B20752
 
Solvens
 
Lyophilisate and solvent 
  
  
BAG: Active AgentDose
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
 
Inactive agents
Sodium Chloride
 
Source
Data was imported : 07.12.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home